The Conversation (0)
EnteroMedics, which develops medical devices for obesity, metabolic diseases and gastrointestinal disorders, today provides a corporate update.
EnteroMedics, which develops medical devices for obesity, metabolic diseases and gastrointestinal disorders, today provides a corporate update.
According to the press release:
“EnteroMedics continued to drive opportunities to expand the Company’s commercial reach, including the announcement of a third adjunctive rescue surgery for a failed gastric sleeve using the Company’s vBloc® Neurometabolic Therapy … patients from those surgeries are reporting weight-loss results in-line with expectations based on the nature of the surgeries.”
The press release goes on to note:
“The Company expanded its current partnerships by announcing that vBloc Therapy is now available to all U.S. veterans at Department of Veterans Affairs (VA) Medical Facilities.”